Breast Cancer Awareness Month Sees Biotech Advancements and Worrying Trends for Young Women

USA News Group News Commentary
Issued on behalf of Oncolytics Biotech Inc.

VANCOUVER, BC, Oct. 15, 2024 /PRNewswire/ -- With every October, breast cancer awareness surges thanks to very effective campaigns and new developments in breast cancer treatment. However, this October has started with some chilling data, including a new report showing that breast cancer diagnoses are spiking among women under 50. Not only did the study estimate that more than 310,000 new cases of invasive breast cancer will be diagnosed in women in 2024 (with more than 42,000 people dying from the disease), but new poll data from BREM also showed that a third of women are skipping recommended screenings due to cost. Thankfully, a report from September showed that while cancer diagnoses are rising, so is the chance of surviving. As Breast Cancer Awareness month continues, so too do biotech developers and their developments, with recent market updates from: Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC), Hologic, Inc. (NASDAQ: HOLX), Novartis AG (NYSE: NVS), Kazia Therapeutics Limited (NASDAQ: KZIA), and Atossa Therapeutics, Inc. (NASDAQ: ATOS).

Read more at prnewswire.com